Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) Long-Term Debt, Maturity, Year Four

2.8 / 5 stars · 68/120 Roast Me

ALPHA TEKNOVA, INC. Long-Term Debt, Maturity, Year Four

ALPHA TEKNOVA, INC. (TKNO) had Long-Term Debt, Maturity, Year Four of $1.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2026-08-06

  • 2026-06-30: Long-Term Debt, Maturity, Year Four $1.10M.
  • 2026-03-31: Long-Term Debt, Maturity, Year Four $1.10M.
  • 2025-12-31: Long-Term Debt, Maturity, Year Four $6.62M.
  • 2025-09-30: Long-Term Debt, Maturity, Year Four $6.62M.
Period endLong-Term Debt, Maturity, Year Four
2026-06-30$1.10M
10-Q · filed 2026-08-06
2026-03-31$1.10M
10-Q · filed 2026-05-07
2025-12-31$6.62M
10-K · filed 2026-03-02
2025-09-30$6.62M
10-Q · filed 2025-11-07
2025-06-30$6.62M
10-Q · filed 2025-08-08
2025-03-31$6.62M
10-Q · filed 2025-05-09
2024-12-31$2.02M
10-K · filed 2025-03-07
2023-12-31$2.53M
10-K · filed 2024-03-27
2023-09-30$2.53M
10-Q · filed 2023-11-13
2023-03-31$4.61M
10-Q · filed 2023-05-11
2022-12-31$6.46M
10-K · filed 2023-03-30
2022-09-30$8.57M
10-Q · filed 2022-11-14
2022-06-30$8.57M
10-Q · filed 2022-08-11
2022-03-31$1.50M
10-Q · filed 2022-05-12
2021-12-31$6.00M
10-K · filed 2022-03-18
2021-09-30$6.00M
10-Q · filed 2021-11-12
2021-06-30$6.00M
10-Q · filed 2021-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92